Welcome to the e-CCO Library!

P597: Optimising therapeutic drug monitoring of adalimumab with dried blood samples in IBD patients: an interim analysis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Berends*1,2, K. Bloem3, R. Talwar1, A. De Vries3, T. Schaap3, A. Strik2, M. Löwenberg2, G. D'Haens2, R. Mathôt1

Created: Friday, 22 February 2019, 9:41 AM
P597: Usefulness of histological monitoring in predicting relapse after de-escalation of thiopurines in Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Yamana, Y.(1)*;Sagami, S.(1);Maeda, M.(1);Karashima, R.(1);Miyatani, Y.(1);Hojo, A.(1);Nakano, M.(1);Maeda, I.(2);Hibi, T.(1);Kobayashi, T.(1,3);
Created: Friday, 14 July 2023, 11:05 AM
P597: Ustekinumab use in Crohn's disease: a tertiary centre experience
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Greenup A., Rosenfeld G., Bressler B.

Created: Wednesday, 20 February 2019, 10:36 AM
P598 Incidence of venous thromboembolic events in patients with ulcerative colitis treated with tofacitinib in the ulcerative colitis clinical development programme: An update as of May 2019
Year: 2020
Source:

ECCO'20 Vienna

Authors:

W.J. Sandborn MD1, J. Panés2, B.E. Sands3, W. Reinisch4, I. Modesto5, C. Su6, F. Steinwurz7, N. Lawendy6, N. Koram5, K. Kwok5, T.V. Jones6, A.J. Thorpe6, D. Quirk6, S. Danese8

Created: Thursday, 30 January 2020, 10:12 AM
P598: Adherence to treatment in IBD: to see beyond motivation
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Poza Cordon1*, C. Suarez Ferrer2,3, O. Crivillen Anguita3, E. Martin Arranz1, M. Jaquotot Herranz1, S. Gomez Senent1, M.D. Martin Arranz1

Created: Thursday, 21 February 2019, 9:14 AM
P598: Indicators for inadequate response among patients with Ulcerative Colitis treated with advanced therapies in German clinical practice
Year: 2022
Source: ECCO'22
Authors: Bokemeyer, B.(1);Picker, N.(2);Kromer, D.(2);Rosin, L.(3);Patel, H.(4);
Created: Friday, 11 February 2022, 3:56 PM
P598: Mucosal and transmural healing during anti-TNF therapy. Is fecal calprotectin a marker of therapeutic response?
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bertani L.*1, Ceccarelli L.2, de Bortoli N.1, Albano E.1, Tapete G.1, Laino G.1, Mumolo G.2, Ricchiuti A.2, Bellini M.2, Marchi S.1, Costa F.2

Created: Wednesday, 20 February 2019, 10:36 AM
P598: Previous Intestinal Resection Is Associated with Postoperative Complications in Crohn’s Disease: A Cohort Study
Year: 2021
Source: ECCO'21 Virtual
Authors: Li, Y.(1);Duan, Y.(1);Zhiyuan, Z.(1);Danhua, Y.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P598: Safety and effectiveness of adalimumab treatment in 1523 patients with ulcerative colitis: Results from a prospective, multi-centre, observational study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

H. Ogata*1, T. Hagiwara2, Y. Ito2, T. Kawaberi2, M. Kobayashi2, T. Hibi3

Created: Friday, 22 February 2019, 9:41 AM
P598: The utility of the “Low Anterior Resection Syndrome SCORE” in assessing the postoperative outcomes of patients undergoing restorative proctocolectomy with ileal pouch anal-anastomosis for Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Perotti, S.(1)*;Mineccia, M.(1);Daperno, M.(2);Massucco, P.(1);Gonella, F.(1);Ferrero , A.(1);
Created: Friday, 14 July 2023, 11:05 AM
P599 Trimester exposure and pregnancy outcomes in women exposed to golimumab: Results from the company pharmacovigilance database
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Esslinger1, M. Otero-Lobato1, S. Gabriel2, M. Clark3, P. Sheridan2, A. Geldhof1

Created: Thursday, 30 January 2020, 10:12 AM
P599: Azathioprine in the prevention of anti-infliximab antibody formation: A pilot dose-finding study
Year: 2022
Source: ECCO'22
Authors: Kojecký, V.(1,2);Wasserbauer , M.(3);Keil, R.(3);
Created: Friday, 11 February 2022, 3:56 PM
P599: Development of an inflammatory bowel disease-specific nutrition screening tool (IBD-NST)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Wall*1, B. Wilson1, J. Sanderson2, M. Lomer1,3

Created: Friday, 22 February 2019, 9:41 AM
P599: Home testing for faecal calprotectin: follow-up results from the first UK trial
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Raker J., Ford C., Pavlidis P., Medcalf L., Choong L.M., Chung-Faye G., Dubois P., Hayee B.

Created: Wednesday, 20 February 2019, 10:36 AM
P599: Perspectives on disease- and treatment-related issues encountered by patients with Inflammatory Bowel Disease: a qualitative concept mapping study
Year: 2021
Source: ECCO'21 Virtual
Authors: Risager Christensen, K.(1);Steenholdt, C.(1);Skougaard, M.(2);Ainsworth, M.A.(3);Brynskov, J.(1);Buhl, S.(1);Kristensen, L.E.(2);Schjødt Jørgensen, T.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P599: Short- and long-term outcome of minimally invasive approach for Crohn’s disease: Comparison between single incision, robotic-assisted and conventional laparoscopy
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Zambonin1*, F. Giudici1, F. Ficari1, F. Rogai2, S. Scaringi3

Created: Thursday, 21 February 2019, 9:14 AM
P600 Vedolizumab dose optimisation: Findings from a Belgian registry
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Louis1, V. Muls2, P. Bossuyt3, A. Colard4, A. Nakad5, D. Baert6, F. Mana7, P. Caenepeel8, S. Vanden Branden9, S. Vermeire10, F. D’Heygere11, B. Strubbe12, A. Cremer13, J.C. Coche14, V. Setakhr15, F. Baert16, A. Vijverman17, J.L. Coenegrachts18, F. Flamme19, A. Hantson20, K. Wijnen20, E. Piters20, G. Hantsbarger21, P. Dolin22

Created: Thursday, 30 January 2020, 10:12 AM
P600: Clinical utility of anti-IFI16 seroreactivity in the response to anti-TNF therapy in IBD
Year: 2018
Source: ECCO '18 Vienna
Authors:

V. Caneparo1,2, B. Verstockt3,4, S. Vermeire3,4, S. Landolfo1, M. Gariglio2, M. De Andrea1,2*

Created: Thursday, 21 February 2019, 9:14 AM
P600: Democratic deliberation to assess Veteran preferences for biosimilar medication switching for the treatment of Inflammatory Bowel Disease in a resource-conscious setting.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ryan, K.(1);Hou, J.K.(2,3)*;Baker, J.(4);Krenz, C.(1);De Vries, R.(1);Waljee, A.K.(4,5);
Created: Friday, 14 July 2023, 11:05 AM